Sign Out
A 0.5 ml dose of the reconstituted vaccine contains not less than 103.3 plaque-forming units (PFU) of the varicella-zoster virus.
VARILRIX is a lyophilised preparation of the live attenuated Oka strain of varicella-zoster virus, obtained by propagation of the virus in MRC5 human diploid cell culture.
VARILRIX meets the World Health Organisation requirements for biological substances and for varicella vaccines.
Excipients/Inactive Ingredients: Powder: amino acids, lactose, mannitol, sorbitol.
Solvent: water for injections.
Neomycin sulphate is present as a residual from the manufacturing process.
